LEGN
NASD Legend Biotech Corp. Sponsored ADR$19.18 ↑ +0.36 (+1.91%) Trading Up from the previous close of $18.82, $0.08 below the day’s high of $19.26
- YTD change
- -11.78%
- vs 20-day SMA
- -0.65%
- vs 200-day SMA
- -14.66%
Price ranges
Price & Performance
+1.31 (+7.57%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 75.2% away from all-time highs of $77.32
- LEGN is down 12% since the beginning of the year
- LEGN is down 42% over the past 12 months
- LEGN is down 4% over the past 1 month
- 8% of all LEGN investors are betting against LEGN
LEGN reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -43.3%.
- Previous minute
- +$0.00
- Last hour
- +$0.36
- Last 5 days
- +3.51%
- vs 8-day SMA
- +3.96%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
